Preventive and Therapeutic Vaccine Market – Global Industry Analysis Report, Share, Growth, Price Trends and Forecast, 2017 – 2024: Global Market Insights Inc. The 2017 Preventive and Therapeutic Vaccine Market forecast report focuses on regional growth for 15+ countries, leading industry companies, applications of Preventive and Therapeutic Vaccine and more with an aim to help take business decisions. Global Preventive and Therapeutic Vaccine Market size is poised to experience high growth, primarily because of its fast-growing nature and expanding market size. Vaccine developments have been considerably increasing since recent past and their adoption is also rising in various regions across the globe. Practices by the major companies, such as consistent research and innovation and development for introducing recent technologies to curb expense and reduce time will spur vaccine market worldwide.
Increasing government funding for vaccine development, rising R&D investments, the introduction of faster vaccine development technologies, and improvements in vaccine design are some of the factors, which will fuel market growth over the coming years. However, the high cost of vaccine storage and transportation and stringent regulations for the approval of vaccines will hamper the market expansion. Global preventive and therapeutic vaccine market is broadly classified into preventive vaccine market and therapeutic vaccine market. Based on the product type, preventive vaccine market is segmented into pediatric and adult vaccines and therapeutic vaccine is segmented into neurological disease vaccines, autoimmune disease vaccines, infectious disease vaccines, and cancer vaccines. Soaring prevalence of diseases among children is resulting in the implementation of awareness programs by governments across the globe. Moreover, significant advancements in vaccinology, such as the emergence, development, and usage of hepatitis B vaccine, should augment the business growth over the coming years. Strategies adopted by major vendors in the market, such as the development of improved influenza vaccine that broaden vaccine-induced immunity, enhancing the vaccine immunogenicity, and introducing alternative delivery will result in greater adoption of influenza vaccine in future. 1|Page